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Infantile Cerebral and Cerebellar Atrophy
Is Associated with a Mutation in the MED17 Subunit
of the Transcription Preinitiation Mediator Complex
Rami Kaufmann,1,2,3,11 Rachel Straussberg,2,3,11 Hanna Mandel,4,11 Aviva Fattal-Valevski,3,5,11
Bruria Ben-Zeev,3,6,11 Adi Naamati,7 Avraham Shaag,1 Shamir Zenvirt,1 Osnat Konen,3,8
Aviva Mimouni-Bloch,9 William B. Dobyns,10 Simon Edvardson,1,11 Ophry Pines,7 and Orly Elpeleg1,*
Primary microcephaly of postnatal onset is a feature of many neurological disorders, mostly associated withmental retardation, seizures,
and spasticity, and it typically carries a grave prognosis. Five infants from four unrelated families of Caucasus Jewish origin presented
soon after birth with spasticity, epilepsy, and profound psychomotor retardation. Head circumference percentiles declined, and brain
MRI disclosed marked cereberal and cerebellar atrophy with severe myelination defect. A search for a common homozygous region
revealed a 2.28 Mb genomic segment on chromosome 11 that encompassed 16 protein-coding genes. A missense mutation in one of
them,MED17, segregated with the disease state in the families and was carried by four of 79 anonymous Caucasus Jews. A corresponding
mutation in the homologous S.cerevisiae gene SRB4 inactivated the protein, according to complementation assays. Screening ofMED17
in additional patients with similar clinical and radiologic findings revealed fourmore patients, all homozygous for the p.L371Pmutation
and all originating from Caucasus Jewish families. We conclude that the p. L371P mutation in MED17 is a founder mutation in the
Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and cerebellar atrophy
with poor myelination.Primary microcephaly of prenatal onset is defined by head
circumference that is more than three standard deviations
(SD) below the age- and sex-adjusted mean and is typically
associated with mental retardation. Abnormal tone and
seizures are common, but usually there are no additional
malformations. Microcephaly of prenatal onset has been
linked to disruption of genes that play a role in cell divi-
sion, chromosome segregation, and centrosome function
(reviewed in 1). Microcephaly of postnatal onset is charac-
terized by postnatal deceleration of head growth, and its
differential diagnosis is wide, including acquired insults
as well as a long list of neurodevelopmental, neurodegen-
erative, and neurometabolic disorders. Significant involve-
ment of the cerebellum and brain stem in these conditions
is uncommon.
The subjects of this study were five patients, four males
and one female from four unrelated Caucasus Jewish fami-
lies; consanguinity was known in only one of the couples.
The pregnancies were uneventful, and the infants were
born at term with normal Apgar scores and appropriate
weight for gestational age. Of note, normal brain structure
and age-appropriate head circumference was noted by
ultrasound performed at 22 gestational wks in one patient
and at birth in another; head circumferences were within
the normal range (32–34 cm) in all of the patients at birth.1Monique and Jacques Roboh Department of Genetic Research, the Departmen
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The AmericanHowever, at 4–9 wks of age, swallowing difficulties leading
to failure to thrive, jitteriness, poor visual fixation and lack
of tracking, truncal arching, and overt seizures became
evident. Shown on physical examination were micro-
cephaly, increased muscle tone, clonus, and exaggerated
deep tendon reflexes. The patients were not dysmorphic,
and there was no indication of other organ involvement.
In the ensuing months, there was no acquisition of devel-
opmental milestones; the patients suffered from marked
spasticity, profound retardation, and occasional seizures;
and progressive microcephaly became evident with a
head circumference of 6 SD at 9 mo of age. At the time
of the report all five patients were alive, aged 5 mo to
15 yrs. EEG disclosed dysmature background with multi-
focal spike and wave activity at 2–4 mo, hypsarrhythmia
at 6–8 mo, and a diffuse slowing of background with bilat-
eral slow, sharp frontotemporal activity at an older age.
Brain MRI revealed severe diffuse cerebral and cerebellar
atrophy already evident at 3 mo of age (Figure 1). Subse-
quent imaging scans were striking for poor myelination,
cerebral and cerebellar atrophy, small thalami, and a thin
brainstem.
Laboratory investigation was normal, including blood
count, electrolytes, creatine kinase, thyroid, renal and liver
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Figure 1. Brain MRI at 3 Months of Age
Coronal (A) and midsagittal (B) T2-weighted magnetic resonance
images illustrating pronounced cerebral and cerebellar atrophy.isoelectrofocusing of transferrins, very long chain fatty
acids, biotinidase activity and carnitine levels in plasma,
and organic acids in urine. Muscle histochemistry and
the activity of the five enzymatic complexes of the mito-
chondrial respiratory chain were normal.
In order to localize the mutated gene, we performed
homozygosity mapping, using the GeneChip Human
Mapping 250K Nsp Array of Affymetrix in the samples of
three patients, as previously described.2 Informed consent
was granted by the parents, and the study was approved
by the Hadassah and Sheba ethical review committees.
A single homozygous region, spanning 2.28 Mb on chro-
mosome 11 (SNP markers rs12363947–rs333027, corre-
sponding to 91.94–94.22 Mb) (positions according to the
March 2006 release of the human genome assembly,
hg18), was shared by the three patients, and the genotype
of the 254 SNPmarkers that are included in this region was
identical. Notably, the three patients did not share any
other genomic region. The common genomic segment
encompassed 16 protein-coding open reading frames.
These genes were prioritized according to their expression
and function (GeneDistiller),3 and the sequence of the
coding exons and the flanking intronic regions ofMRE11A
(MIM 600814), PANX1 (MIM 608420), MED17 (MIM668 The American Journal of Human Genetics 87, 667–670, Novemb603810) and TAF1D (MIM 612823) was determined. No
mutation was identified in MRE11A, PANX1, or TAF1D;
however, in MED17, which spans 12 exons encoding 651
amino acids, a single mutation was detected in exon 7,
c.1112 T>C (Figure 2) (GI: 18089269), which is predicted
to result in the substitution of leucine at codon 371 by
proline (p.L371P). The five patients were homozygous,
and seven parents and three of five available siblings
were heterozygous for the mutation. We then screened
MED17 in additional patients with similar clinical and
radiologic findings and identified four more patients, all
homozygous for the p.L371P mutation and all originating
from Caucasus Jewish families. A maximum LOD score
of ~2.4 was obtained for the p.L371P mutation with zero
recombination via the SuperLink program for the families
of the nine Caucasus Jewish patients. In order to estimate
the prevalence of the mutation among Jews of Caucasus
origin, we determined the sequence of exon 7 of MED17
in the DNA samples of 79 anonymous Caucasus and Bu-
kharin Jews who requested premarital or prenatal genetic
screening. Four of the 79 anonymous individuals carried
the mutation; no carriers were detected among 110 anon-
ymous Ashkenazi Jews and 113 anonymous individuals of
Arab Moslem origin. On the basis of the identical SNP
haplotype in the three unrelated patients who were sub-
jected to the 250K SNP analysis, the presence of homozy-
gosity for the mutation in nine patients of the same ethnic
origin, and the considerable prevalence of a carrier state
among healthy individuals of this ethnicity, we believe
that p.L371P is a founder mutation in the Caucasus Jewish
community.
The transcription of protein-coding genes is initiated by
the binding of a ~2 MDa preinitiation complex to the
promoter DNA. This complex consists of transcription
factors, the Mediator complex, and RNA polymerase II.
The Mediator complex, itself assembled of ~30 subunits,
is regarded as a bridge to convey information from gene-
specific regulatory proteins to the basal RNA polymerase
II transcription machinery (reviewed in 4). MED17 is
a central component ofMediator, required for the structureFigure 2. The c.1112T>C (p.L371P)
Mutation in MED17
(A) Exon 7 of MED17. The mutated nucle-
otide is indicated by an arrow. The patient,
an obligate heterozygote, and a control
sample are shown in the upper, middle,
and lower lanes, respectively.
(B) Amino acid conservation at and
around the mutated codon (asterisk) site.
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Figure 3. SRB4-M504P, Corresponding to Human MED17-
L371P, Cannot Complement the Depletion of Active SRB4 in
Yeast
The wild-type (Z579) and a mutant expressing temperature-sensi-
tive ts-SRB4 (Z628) were transformed with the indicated plasmids.
Cultures were serially diluted at 10-fold intervals, and 10 ml of each
was spotted onto YPD plates, which were incubated at 25C
(permissive temperature, left panel) or 37C (restrictive tempera-
ture, right panel) for 2 days.and integrity of the complex; the elimination of its
homolog in yeast (SRB4) and Drosophila (TRAP80) has
resulted in reduction of transcriptional activation and
lethality of the mutants.5,6 On the basis of the functional
homology and the relatively high conservation around
the mutation site, we used a yeast SRB4 conditional deple-
tion mutant to examine the potential pathogenicity of
the p.L371P mutation. To this end, we mutated Met504
(which corresponds to Leu371 in the human MED17
subunit) of the yeast SRB4 to proline (M504P). The exper-
imental setup was based on the yeast strain Z628 (ts-SRB4),
which expresses a temperature-sensitive mutant of SRB4,
thus enabling the strain to grow at 25C but not at
37C.5 Transformations were conducted with yeast SRB4,
rather than human MED17, because of its overall low
amino acid sequence conservation. Transformation of
the ts-SRB4 strain with a plasmid encoding the wild-type
SRB4 fully complemented the ts-SRB4 activity (Figure 3).
In contrast, the mutant of interest, SRB4-M504P, did not
complement the ts-SRB4 activity, indicating that it was
functionally inactive. Notably, the expression of SRB4-
M504P in a wild-type background did not affect growth,
indicating thatM504P is a recessivemutation. As a control,
we also mutated methionine 504 of SRB4 to leucine, the
human residue at this position (M504L); as expected,
this mutant fully complemented the ts-SRB4 activity
(Figure 3). Together, these results underscore the impor-
tance of the 504 residue (codon 371 in human) and the
unfavorable functional consequences of its replacement
by proline.
Until now, defects in two Mediator subunits have been
associated with disease in human. Charcot-Marie-Tooth
disease type 2B2 (MIM 605589), an axonal neuropathy
transmitted in an autosomal-recessive manner, is caused
by a missense mutation in MED25 (MIM 610197),7 and
two x-linked dysmorphic mental retardation syndromes,
Opitz-Kaveggia (FG) syndrome (MIM 305450) and Fryns-
Lujan syndrome (MIM 309520), were associated with
mutations in MED12 (MIM 300188).8,9 The organ-specific
involvement in defects of each of the three subunits,
MED12, MED17, andMED25, could probably be explainedThe Americanby a recent observation in rodent fibroblasts, where
MED17 was shown to be essential for the expression of
only aminority of the genes. The recruitment of RNA poly-
merase II to gene promoters and the initiation of transcrip-
tion were maintained even when the level of MED17 was
nearly abolished.10 In view of the seemingly normal
prenatal development and the prominent white matter
involvement postnatally, it is tempting to speculate that
the MED17 mutation interferes with the expression of
the gene(s) involved with oligodendrocyte development,
a process that in human commences only after birth.
The Jewish community in the Caucasus region is
believed to originate from today’s southern Iran. The
Caucasus Jews were genetically isolated for more than
2500 yrs by their language and religious practice. Most
members of this community immigrated to Israel in
1970–1990. Still, marriage within the community is pre-
ferred, currently approaching 45% (J. Zlotogora, personal
communication). The fact that three of the four families
denied consanguinity and the relatively small size of
the common homozygous genomic region attest to the
ancient nature of the causative mutation. Although the
number of anonymous controls is small, our results
suggest that a carrier state for the MED17 p.L371P muta-
tion is of considerable prevalence within this ethnic group.
Screening for the mutation is warranted among Caucasus
Jewish couples, which would enable a better estimation
of the carrier rate and identify couples at risk.Acknowledgments
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